Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma-Reference-Cited by-同舟云学术

Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma

Published:2020-08-28 Issue:5 Volume:38 Page:698-704
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Della Starza Irene¹^ORCID,De Novi Lucia Anna¹,Cavalli Marzia¹,Novelli Noemi¹,Soscia Roberta¹,Genuardi Elisa²,Mantoan Barbara²,Drandi Daniela²,Ferrante Martina²,Monitillo Luigia²,Barbero Daniela²,Ciabatti Elena³,Grassi Susanna⁴,Bomben Riccardo⁵,Degan Massimo⁵,Gattei Valter⁵,Galimberti Sara³,Di Rocco Alice¹,Martelli Maurizio¹,Cortelazzo Sergio⁶,Guarini Anna⁷,Foà Robin¹,Ladetto Marco⁸,Ferrero Simone²⁹,Del Giudice Ilaria¹,

Affiliation:

1. Hematology Department of Translational and Precision Medicine “Sapienza” University of Roma Rome Italy

2. Division of Hematology Department of Molecular Biotechnologies and Health Sciences University of Torino Torino Italy

3. Division of Hematology Department of Oncology Santa Chiara Hospital Pisa Italy

4. Department of Medical Biotechnologies University of Siena Siena Italy

5. Clinical and Experimental Onco‐Haematology Unit Centro di Riferimento Oncologico, I.R.C.C.S. Aviano Italy

6. Hematology, Medical Oncology and Hematology Division “Istituto Clinico Humanitas Gavazzeni” Bergamo Italy

7. Department of Molecular Medicine “Sapienza” University of Roma Rome Italy

8. Division of Hematology Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo Alessandria Italy

9. Division of Hematology AOU “Città della Salute e della Scienza di Torino” Torino Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2792

Reference32 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. How to manage mantle cell lymphoma

3. Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

4. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

5. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: — Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?;Frontiers in Oncology;2023-03-14

2. Molecular characterization of a Tunisian B-lineage leukemia using Kde gene rearrangements;Journal of Cancer Prevention & Current Research;2022-02-28

3. Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review;Molecular Diagnosis & Therapy;2021-11-13